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Abstract
This paper reports a droplet-based microfluidics approach to fabricate a large number of 
monodisperse, portable microtissues, each in an individual drop. We use water-water-oil double 
emulsions as templates and spatially assemble hepatocytes in the core and fibroblasts in the shell, 
forming a 3D liver model in a drop.
Nearly all tissues are integrated three-dimensional (3D) structures of multiple types of cells 
and extracellular matrices (ECMs).1,2 The function of a tissue is typically governed by 
multiple cues, ranging from intercellular signalings to cell interactions with the surrounding 
ECMs.3-6 Liver, for example, consists of primary hepatocytes, hepatic stellate cells, Kupffer 
cells, endothelial cells, and fibroblasts, which are arranged in a 3D scaffold.7 Hepatocytes 
alone show very low levels of liver-specific functions, because conventional two-
dimensional (2D) cultures of a monolayer of these cells on a plastic dish are poor mimics of 
tissues found in vivo.8 Instead, improved functionality of liver tissue mimics requires the 
development of 3D models that consist of simplified but similar scaffolds with multiple 
types of cells embedded in ECMs and that express improved functionality.9-12
Well-defined spatial distributions of different cells in 3D architectures made of 
biocompatible ECMs are required to construct artificial tissues that mimic the in vivo 
microenvironment. Miniaturized, multiwell culture systems,13-15 3D cell printing,16-18 and 
3D cell molding,19 have each been used to develop 3D artificial liver models. In each case, 
hepatocytes are co-cultured with other cells in micro-patterned 3D scaffolds; they are 
separated in space while close enough to each other that they can interact biochemically. 
Therefore, different cells are able to coordinate both homotypic and heterotypic cell-cell 
interactions and show improved liver-specific functions.20-22 However, these technologies 
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are limited in terms of uniformity, portability and quantity; versatile human microtissues 
composed of different cells in precisely controlled 3D structures are, as yet, unavailable.
Droplet-based microfluidics can produce monodisperse droplets whose size can be precisely 
controlled and whose internal structure can be tailored to incorporate different cells in 
designated locations.23-26 However, previous microfluidic-based research focused on 
biocompatible hydrogel microparticles templated from single water-in-oil (w/o) 
emulsions.27-31 These would lead to over-simplified 3D cellular microenvironment with 
limitations both in terms of impaired cell-cell contact and undefined spatial distribution of 
different cells in the drops. More sophisticated structures with well-defined 3D architectures 
are, therefore, required.
In this paper, we report the first study of reconstituting “organ in a droplet” by controlled 
assembly of heterotypic cells in biocompatible 3D core-shell hydrogel scaffolds. We use 
droplet-based microfluidics to produce highly monodisperse structures that enable multiple 
types of cells to be optimally arranged to create an artificial liver in a drop. We produce 
water-water-oil (w/w/o) double emulsions which we use as templates to successfully 
integrate the 3D core-shell scaffold with hepatocytes in the core surrounded by fibroblasts in 
the shell. We cross-link the shell of alginate hydrogel by triggered release of calcium 
cations; this method avoids exposure to harsh environments during fabrication and creates 
structures with good integrity and high permeability. Hepatocytes and fibroblasts co-cultured 
in the drop develop both homotypic and heterotypic cell-cell interactions, which cannot be 
achieved in a 2D culture system. Albumin secretion and urea metabolism, which are good 
assays of liver-specific functions, both exhibit higher activity in the microtissues as 
compared to that in hepatocytes alone.
To construct the core-shell scaffolds, we use w/w/o double emulsions as templates and 
generate core-shell droplets in a flow-focusing microfluidic device, as shown in Figure 1. 
The inner phase is cell culture medium and the middle phase is alginate aqueous solution, a 
well-studied biocompatible polymer that shows excellent cell function and survival in the 
network.32 The inner phase co-flows with the middle phase due to their low Reynolds 
numbers; a fluorinated carbon oil at the cross-junction forms monodisperse droplets 
consisting of an aqueous core and a hydrogel shell (Figures 1b and c). Instead of cross-
linking by UV exposure, which is generally harmful to cells, we introduce an additional oil 
flow containing 0.15% acetic acid downstream and trigger release of Ca2+ from the Ca-
EDTA complex in the alginate solution; the divalent Ca2+ subsequently binds to two 
different carboxylic groups of alginate chains, forming a cross-linked 3D network (Figure 
1a). The in situ cross-linking locks alginate in the shell, which is directly visualized with 
fluorescent confocal microscopy by labeling alginate with fluorescein (see Supporting 
Information, Scheme S1), as shown in the inset of Figure 1d. Using these w/w/o double 
emulsions as templates, we are able to fabricate a large number of monodisperse core-shell 
droplets with well-controlled internal structure (Diameter=169 ± 6 μm, see Supporting 
Information, Figure S1).
To assemble hepatocytes in the core, we suspend hepatocytes in the cell culture medium and 
inject them with the inner phase (see Supporting Information, Figure S2). Hepatocytes are 
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subsequently encapsulated in the core by the hydrogel shell and they start to form aggregates 
after several days' culture, as shown in Figure 2a. The aggregate is a common phenotype of 
healthy hepatocytes and is clear proof of direct cell-cell contacts due to homotypic cell-cell 
interactions. Similarly, we distribute fibroblasts in the shell by premixing them with the 
alginate solution and injecting them with the middle phase (see Supporting Information, 
Figure S3). The fibroblasts are then confined in the shell by the cross-linked alginate 
network and there are no cells observed in the core, as shown in Figure 2b. Random co-
cultures of hepatocytes and fibroblasts in the same compartment will have lower liver-
specific functions due to the lost balance of homotypic and heterotypic cell-cell 
interactions;13 therefore, to mimick the 3D structure of human liver in vivo and to develop 
an artificial liver in each drop, we simultaneously assemble hepatocytes (HepG2 cells) in the 
core surrounded by fibroblasts (NIH-3T3 cells) in the shell, forming a spheroid of different 
cells embedded in a 3D ECM (see Supporting Information, Figure S4 and Movie S1). In our 
study, the heterocellular spheroids are generated by one-step in situ cross-linking of alginate 
in the shell, after which the spheroids are quickly transferred to cell culture medium. The 
exposure of cells to mild acidic conditions during the whole process is limited and has little 
effect on the viability of cells, as evidenced by the predominance of live cells (green) and the 
complete lack of any dead cells (red) in the live-dead assay, as shown in Figure 2c.
We culture the core-shell spheroids in the medium at 37°C. The spheroids maintain their 
spherical shape even for two weeks' culture, during which time the cells grow denser, as 
shown in Figures 3a-c. The distinct spherical shape is also observed in freeze-dried samples 
using scanning electron microscopy, as shown in Figure 3d and magnified in Figure 3e. 
Moreover, the cross-section of a freeze-dried spheroid reveals dense cell aggregates in the 
core and dispersed cells in the shell, as shown in Figure 3f. These observations suggest that 
the hydrogel shell of cross-linked alginate is mechanically strong. This strength, together 
with the portability of each microtissue in a drop enables us to store them at -80°C, thaw 
them at 37°C and culture them again without destroying the structure or affecting the 
viability of cells, as shown in Figure 3g. While the shell of alginate hydrogel is robust, it is 
also highly permeable, enabling nutrients and metabolites to pass through; therefore, cells in 
the spheroids can be cultured for long periods of time, as evidenced by the high viability of 
cells cultured in the spheroids. After 10 days' culture, cells are predominantly live (green) 
and there is complete lack of dead cells (red), as revealed by a live-dead staining kit (Figure 
3h). During the period, cells have grown denser. However, because cells can't attach to 
unmodified alginate network, cells can't migrate from one layer to the other over time. 
Therefore, hepatocytes and fibroblasts remain spatially separated, which is beneficial for 
their liver-specific functions. Even after 14 days, a slight decrease in cell viability is 
observed; the percentage of dead cells is about 34%, as shown in Figure 3i. It is possible that 
a hypoxic core developed at day 14 due to cell proliferation and the resulting high cell 
density.
To measure the liver-specific functions of the microtissues in a drop, we monitor their 
albumin secretion and urea synthesis over time; the two metabolites are key biomarkers of 
the liver and this response has been widely used in drug screening.33 We culture two 
samples with same amount of hepatocytes, one in the core-shell structure with fibroblasts in 
the shell and the other without fibroblasts, and monitor the concentration of albumin and 
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urea in the medium using albumin and urea assay kits, respectively. Compared to monotypic 
culture of hepatocytes alone, co-culture of hepatocytes and fibroblasts in the core-shell 
spheroids displays both increased albumin secretion and urea synthesis, as shown in Figures 
4a and b. The enhanced liver-specific functions substantially differentiate our 3D microscale 
co-culture from conventional monotypic cell culture (statistically significant, *p<0.01). 
These results suggest that co-culture of hepatocytes and fibroblasts embedded in the 3D 
core-shell scaffold is a good model of the liver in vitro and has a balance of homotypic and 
heterotypic cell-cell interactions, which are beneficial for the expressions of their liver-
specific functions. High-throughput assays of human tissue responses using these uniform, 
portable microtissues, each in a drop, will be valuable for rapid assessment of drugs, 
chemicals and cosmetics.
Conclusions
We use droplet-based microfluidics and hierarchically assemble hepatocytes and fibroblasts 
into a 3D core-shell scaffold, forming an artificial liver in each drop. The strong mechanical 
property and high permeability of the hydrogel shell enable cells in the spheroids to be 
cultured for long periods of time. Within the optimized microscale structure that promotes 
both homotypic and heterotypic cell-cell interactions, co-culture of hepatocytes in the core 
surrounded by fibroblasts in shell successfully expresses high-level liver-specific functions. 
Thousands of monodisperse microtissues, each in an individual drop, are achievable using 
the microfluidics technology, and each maintains enhanced liver-specific functions. In 
addition, hepatocytes and fibroblasts can easily be replaced with other cells to construct 
other tissue models and study cell-to-cell interaction in general. Thus, these structures are a 
promising in vitro liver model for high-throughput drug screening assays.34,35
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Figure 1. 
Construction of 3D scaffold in a drop consisting an aqueous core and a hydrogel shell. a) 
Cross-link of alginate network by triggered release of Ca2+ from Ca-EDTA complex. b) 
Schematic diagram of the PDMS device. c) Fabrication of core-shell droplets using w/w/o 
double emulsions as templates. Alginate in the shell is cross-linked by in situ triggered 
release of Ca2+. d) Monodisperse core-shell droplets generated using the droplet-based 
microfluidics. The shell of alginate hydrogel is clearly identified under confocal microscope 
when alginate is labeled with fluorescein, as shown in the inset.
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Figure 2. 
Spatial assembly of different cells in the 3D core-shell scaffold. a) HepG2 cells confined in 
the core by the hydrogel shell. b) NIH-3T3 fibroblasts immobilized by the cross-linked 
alginate network in the shell. c) Simultaneous assembly of hepatocytes in the core and 
fibroblasts in the shell, forming an artificial liver in a drop. Cell viability is characterized by 
Calcein AM/EthD-1 staining kit. The scale bars are 100 μm.
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Figure 3. 
Co-culture of hepatocytes and fibroblasts in the core-shell spheroids. Morphology of the 
heterocellular spheroids and viability of the cells in the hydrogel scaffold. a-c) Co-culture of 
hepatocytes in the core and fibroblasts in the shell for 1 day, 7 days and 14 days, 
respectively. The heterocellular spheroids maintain their spherical morphology over time. d) 
SEM image and e) magnified image show individual spheroids that maintain their structural 
integrity after freeze-drying. f) Spatially confined cell ensembles in the core-shell structure. 
g) High viability of cells encapsulated in the spheroids after being frozen at -80°C for two 
weeks and then thawed at 37°C. Cells are predominantly alive (green) and there is complete 
lack of dead cells (red). h) Co-culture of cells encapsulated in the spheroids for 10 days 
shows high cell viability. i) The viability of cells cultured for 14 days decreases slightly, as 
evidenced by the appearance of dead cells (red). Cell viability is characterized by Calcein 
AM/EthD-1 staining kit. The scale bar is 100 μm in all images.
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Figure 4. 
Comprehensive assays of liver-specific functions of hepatocyte/fibroblast co-culture and 
hepatocyte culture. a) Albumin secretion and b) urea synthesis of HepG2/NIH-3T3 co-
culture and HepG2 culture measured over seven days. The liver-specific functions enhanced 
by the co-culture of hepatocytes and fibroblasts in the 3D core-shell spheroids are 
statistically significant (*p<0.01).
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